These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 29489901)
1. Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas. Michaud K; de Tayrac M; D'Astous M; Paquet C; Gould PV; Saikali S PLoS One; 2018; 13(2):e0193213. PubMed ID: 29489901 [TBL] [Abstract][Full Text] [Related]
2. Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines. Michaud K; de Tayrac M; D'Astous M; Duval C; Paquet C; Samassekou O; Gould PV; Saikali S PLoS One; 2016; 11(12):e0168728. PubMed ID: 28030632 [TBL] [Abstract][Full Text] [Related]
4. Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization. Jeon YK; Park K; Park CK; Paek SH; Jung HW; Park SH Neuropathology; 2007 Feb; 27(1):10-20. PubMed ID: 17319279 [TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin A and topoisomerase IIalpha of oligodendrogliomas is correlated with tumour grade, MIB-1 labelling index and survival. Park SH; Suh YL Histopathology; 2003 Apr; 42(4):395-402. PubMed ID: 12653952 [TBL] [Abstract][Full Text] [Related]
6. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma. Deininger MH; Weller M; Streffer J; Meyermann R Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558 [TBL] [Abstract][Full Text] [Related]
7. CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas. Bortolotto S; Chiadò-Piat L; Cavalla P; Bosone I; Chiò A; Mauro A; Schiffer D Int J Cancer; 2000 Nov; 88(4):554-7. PubMed ID: 11058870 [TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas. Godfraind C; Rousseau E; Ruchoux MM; Scaravilli F; Vikkula M Neuropathol Appl Neurobiol; 2003 Oct; 29(5):462-71. PubMed ID: 14507338 [TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas. Watanabe T; Nakamura M; Yonekawa Y; Kleihues P; Ohgaki H Acta Neuropathol; 2001 Mar; 101(3):185-9. PubMed ID: 11307615 [TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857 [TBL] [Abstract][Full Text] [Related]
11. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas. Xiong J; Liu Y; Wang Y; Ke RH; Mao Y; Ye ZR Chin Med J (Engl); 2010 Dec; 123(24):3566-73. PubMed ID: 22166632 [TBL] [Abstract][Full Text] [Related]
12. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. Fallon KB; Palmer CA; Roth KA; Nabors LB; Wang W; Carpenter M; Banerjee R; Forsyth P; Rich K; Perry A J Neuropathol Exp Neurol; 2004 Apr; 63(4):314-22. PubMed ID: 15099021 [TBL] [Abstract][Full Text] [Related]
14. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression. Hoang-Xuan K; He J; Huguet S; Mokhtari K; Marie Y; Kujas M; Leuraud P; Capelle L; Delattre JY; Poirier J; Broët P; Sanson M Neurology; 2001 Oct; 57(7):1278-81. PubMed ID: 11591848 [TBL] [Abstract][Full Text] [Related]
15. Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade. Iwadate Y; Matsutani T; Hara A; Hirono S; Ikegami S; Kobayashi M; Ito D; Kawauchi D; Horiguchi K; Tamiya A; Higuchi Y J Neurooncol; 2019 Jan; 141(1):205-211. PubMed ID: 30565028 [TBL] [Abstract][Full Text] [Related]
16. Prognostic stratification of patients with anaplastic gliomas according to genetic profile. Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124 [TBL] [Abstract][Full Text] [Related]
17. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors]. Absaliamova OV; Korshunov AG; Loshakov VA; Kobiakov GL; Golanov AV; Urakov SV; Amanov RD; Lichinitser MR Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):17-23; discussion 23-4. PubMed ID: 19507310 [TBL] [Abstract][Full Text] [Related]
18. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas. Shao J; Li Y; Li H; Wu Q; Hou J; Liew C Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078 [TBL] [Abstract][Full Text] [Related]
19. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. Cairncross JG; Ueki K; Zlatescu MC; Lisle DK; Finkelstein DM; Hammond RR; Silver JS; Stark PC; Macdonald DR; Ino Y; Ramsay DA; Louis DN J Natl Cancer Inst; 1998 Oct; 90(19):1473-9. PubMed ID: 9776413 [TBL] [Abstract][Full Text] [Related]
20. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]